Earnings6 reported quarters · next on Feb 17, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q3 FY2026reported Nov 4, 2026
$1.77
$1.76
$267.3M
$270.1M
EPS in lineRevenue in line
Q2 FY2026reported Jul 30, 2026
$1.81
$1.67
$264.0M
$261.9M
EPS beatRevenue in line
Q1 FY2026reported Apr 30, 2026
$2.86
$2.78
$308.8M
$307.8M
EPS beatRevenue in line
Q4 FY2025reported Feb 18, 2026
$3.21
$3.19
$308.1M
$308.1M
EPS in lineRevenue in line
Q3 FY2025reported Nov 5, 2025
$1.78
$1.78
$261.1M
$307.9M
EPS in lineRevenue miss
Q2 FY2025reported Aug 6, 2025
$1.53
$1.37
$247.5M
$240.9M
EPS beatRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Analysts
Analyst ratings and price targets
Past year Each firm's latest target, newest first
Each firm's latest price target on LOPE, newest first
Firm
Rating
Target
Action
Date
BMO Capital
Outperform
$182
Cut from $185
Barrington
Not stated
$200
Target set
Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.
1 other firm rated LOPE in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 9, 2026.
Dr. W. Stan Meyer’s pay came to $1.5M for fiscal 2025.
Executive
Salary
Stock awards
Other
Total
Dr. W. Stan MeyerChief Operating Officer
$390K
$647K
$446K
$1.5M
Daniel E. BachusChief Financial Officer (Principal Financial Officer)
$390K
$647K
$441K
$1.5M
Dilek MarshChief Information Officer
$333K
$450K
$170K
$953K
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
13F filings13F positions as of Jun 30, 2026
Institutional holders
Holder
Value
Shares
Shares vs prior qtr
% of shares out
BlackRock, Inc.
$397.7M
2,778,662
-1.2%
10.62%
FMR LLC
$292.7M
2,045,279
-23.7%
7.82%
Vanguard Portfolio Management LLC
$183.1M
1,279,119
-1.1%
4.89%
Vanguard Capital Management LLC
$171.0M
1,194,579
-2.6%
4.57%
William Blair Investment Management, LLC
$148.7M
1,038,828
+6.0%
3.97%
Reinhart Partners, LLC.
$126.4M
882,927
+36.9%
3.37%
State Street Corp
$121.5M
848,871
-1.3%
3.24%
Dimensional Fund Advisors LP
$89.7M
626,554
+0.8%
2.39%
Gw&K Investment Management, LLC
$88.3M
616,654
-14.8%
2.36%
Riverbridge Partners LLC
$79.5M
555,692
-22.5%
2.12%
Van Berkom & Associates Inc.
$78.0M
544,863
-6.9%
2.08%
Geode Capital Management, LLC
$77.6M
542,012
-4.3%
2.07%
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
STOCK Act6 disclosures of 6 on record · median 35d of the 45 allowed
Congress trades in LOPE
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
+11.3%since the saleEstimated exit price $105.73, close on Thu Mar 15, 2018Current price $117.69, close on Fri Nov 6
Mar 15, 2018
Oct 2, 2018
201d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
The largest estimated position is in the $15,001 - $50,000 band. Estimate, as of Nov 9, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on LOPE show and how current they are.
Which members of Congress have traded LOPE?
Josh Gottheimer and Gilbert Ray Cisneros, Jr. disclosed LOPE transactions in the filings shown here.
Which members of Congress hold LOPE?
2 members of Congress report a position in LOPE in the estimate we hold as of Nov 9, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are LOPE trades disclosed?
Congressional disclosures took a median of 35 days, against the 45 the STOCK Act allows.